November 9-11, 2020 | Virtual Conference

Speakers

Suzanne McLeod

Manager, REMS and Drug Safety
Hikma Pharmaceuticals

Suzanne McLeod is a graduate of Austin Peay State University with a BA in Chemistry. She began her work in the generic pharmaceutical industry in 2008 and is currently a Manager of REMS for Hikma Pharmaceuticals USA Inc. Suzanne has been involved in building and implementing shared REMS programs since 2009 as a member of the original IWG for the Extended Release/Long Acting Opioid that was approved in 2012. She is the FDA Liaison for several approved shared REMS programs and is an active participant at the subteam level for the shared programs she manages for Hikma, including the Opioid Analgesic REMS Program, BTOD REMS Program, Alosetron REMS Program, and Bosentan REMS Program. Suzanne has three sons and three grandsons and enjoys musical theater, traveling, reading, and spoiling her grandsons.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content